SRx Health Solutions Inc. (SRXH)

SRx Health Solutions Cash Flow Statement

Financials in millions CAD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-0.17	-22.77	-39.32	3.39	-59.44
Depreciation & Amortization	0.16	1.87	3.56	5.51	6.62
Stock-Based Compensation	0.83	1.77	2.97	4.19	19.27
Other Adjustments	-5.61	9.33	20.84	-23.1	25.87
Change in Receivables	-1.15	2.39	-0.07	-2.14	1.19
Changes in Inventories	2.74	3.65	-6.82	-0.64	1.45
Changes in Accounts Payable	-1.16	4	-0.76	0.77	-2.45
Changes in Accrued Expenses	-0.3	-0.76	0.1	-	-
Changes in Other Operating Activities	0.29	0.63	-1.05	0.16	-0.03
Operating Cash Flow	-4.36	0.1	-20.55	-11.86	-7.51
Capital Expenditures	-0.04	-0.02	-0.2	-0.35	-0.15
Other Investing Activities	-2.21	-	-	-	-
Investing Cash Flow	-2.25	-0.02	-0.2	-0.35	-0.15
Short-Term Debt Issued	-	-	0.41	-	-
Short-Term Debt Repaid	-	-	-0.25	-	-
Net Short-Term Debt Issued (Repaid)	-	-	0.17	-	-
Long-Term Debt Issued	12.43	14.75	12.32	11.54	8.98
Long-Term Debt Repaid	-11.76	-19.6	-11.09	-14.41	-18.88
Net Long-Term Debt Issued (Repaid)	0.67	-4.85	1.23	-2.88	-9.91
Issuance of Common Stock	4.75	-	-	41.78	19.1
Repurchase of Common Stock	-0.21	-	-	-1.6	-
Net Common Stock Issued (Repurchased)	4.55	-	-	40.18	19.1
Other Financing Activities	-	-0.24	-0.11	-0.14	-0.09
Financing Cash Flow	5.22	-5.1	1.28	37.16	9.11
Net Cash Flow	-1.39	-5.02	-19.47	24.95	1.46
Beginning Cash & Cash Equivalents	4.46	9.47	28.94	3.99	2.53
Ending Cash & Cash Equivalents	3.07	4.46	9.47	28.94	3.99
Free Cash Flow	-4.4	0.08	-20.75	-12.21	-7.66
FCF Margin	-12.57%	0.20%	-37.96%	-26.54%	-17.98%
Free Cash Flow Per Share	-2.72	0.11	-31.11	-24.53	-41.18
Levered Free Cash Flow	2.2	-18.26	-43.1	5.96	-63.89
Unlevered Free Cash Flow	-3.93	-11.81	-43.94	-11.64	-21.87

Updated Dec 31, 2024. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q